• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK; IN-VITRO DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ORTHO-CLINICAL DIAGNOSTICS VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK; IN-VITRO DIAGNOSTIC Back to Search Results
Catalog Number 1912997
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/30/2018
Event Type  malfunction  
Manufacturer Narrative
The investigation determined higher than expected vitros tsh results were obtained from a single (b)(6) proficiency sample tested on three different vitros 5600 integrated systems.A definitive assignable cause for the higher than expected vitros tsh (b)(6) proficiency sample results could not be determined.Based on historical quality control results, a vitros tsh lots 5570 and 5610 performance issue is not a likely contributor to the event.There is also no indication of any instrument malfunction and unexpected instrument performance is not a likely contributor to the events.The most likely assignable cause for the higher than expected vitros tsh results for (b)(6) is the condition of the sample itself as the sample was reported by the customer to be greenish in color.Additionally, storage and handling of the sample cannot be ruled out as a contributing factor.
 
Event Description
The customer obtained higher than expected vitros tsh results on a proficiency sample from (b)(6) on three different vitros 5600 integrated systems when compared to the target mean result obtained from the (b)(6) linearity survey.(b)(6) results of 0.506, 0.537, 0.54, 0.564 and 0.499 miu/l vs.The expected result of 0.378 miu/l biased results of the direction and magnitude observed could lead to inappropriate physician action.The higher than expected vitros tsh (b)(6) proficiency sample results were from non-patient fluids and were not reported to the proficiency provider.There was no indication that patient samples were affected, however, the investigation could not conclude patient samples were not affected or would not be affected if the event were to recur undetected.This report is number two of two 3500a forms filed for this event, as two devices were affected.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITROS IMMUNODIAGNOSTIC PRODUCTS TSH REAGENT PACK
Type of Device
IN-VITRO DIAGNOSTIC
Manufacturer (Section D)
ORTHO-CLINICAL DIAGNOSTICS
100 indigo creek drive
rochester NY 14626
Manufacturer (Section G)
ORTHO CLINICAL DIAGNOSTICS
felindre meadows
pencoed
bridgend, wales CF35 5PZ
UK   CF35 5PZ
Manufacturer Contact
james a stevens
100 indigo creek drive
rochester, NY 14626
5854533000
MDR Report Key7558326
MDR Text Key110384416
Report Number3007111389-2018-00071
Device Sequence Number1
Product Code JLW
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 05/31/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/26/2018
Device Catalogue Number1912997
Device Lot Number5610
Other Device ID Number10758750000227
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 05/03/2018
Initial Date FDA Received05/31/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/24/2018
Is the Device Single Use? No
Type of Device Usage N
Patient Sequence Number1
-
-